Omeprazole is not inherently dangerous, but long-term use carries real risks that short-term use does not. For most people taking it for a few weeks to treat heartburn or an ulcer, the drug is safe and effective. The concerns start when weeks turn into months or years, often without a clear medical reason to keep going. That’s when the side effect profile shifts from minimal to worth paying attention to.
How Omeprazole Works
Omeprazole is a proton pump inhibitor, or PPI. It shuts down acid production in your stomach by permanently disabling the molecular pumps that release acid into your digestive tract. The drug is actually a prodrug, meaning it only becomes active once it reaches the acidic environment of your stomach lining. Once activated, it locks onto those acid pumps through a chemical bond that doesn’t let go.
Because the bond is permanent, your body has to build entirely new pumps to restore acid production. That’s why a single dose suppresses acid for far longer than the drug stays in your bloodstream (omeprazole’s half-life in the blood is only about 60 minutes). This powerful suppression is exactly what makes it effective for healing ulcers and inflamed esophageal tissue. It’s also what makes the long-term tradeoffs worth understanding.
Kidney Function
One of the more serious concerns with prolonged omeprazole use is kidney damage. PPIs have been linked to a condition called acute interstitial nephritis, where the kidney tissue becomes inflamed, and to a gradual decline in overall kidney function over time.
A study published in PLOS ONE found that omeprazole users had a roughly 7.4 times higher risk of progressing to worse stages of chronic kidney disease compared to non-users. That’s a striking number. The early theory was that repeated bouts of acute kidney inflammation could scar the tissue and cause cumulative damage. This risk is most relevant to people who have been on omeprazole for months or years, not those finishing a short course.
Vitamin and Mineral Absorption
Your stomach acid does more than digest food. It’s essential for absorbing certain nutrients, and suppressing it long-term can create deficiencies that affect your whole body.
Vitamin B12 is the best-studied example. A large analysis published in JAMA found that people who used PPIs for two or more years had a 65% higher risk of B12 deficiency compared to non-users. B12 requires stomach acid to be separated from the proteins it’s bound to in food. Without enough acid, the vitamin passes through unabsorbed. B12 deficiency can cause fatigue, nerve tingling, memory problems, and mood changes, symptoms that are easy to blame on aging or stress.
Magnesium deficiency is another recognized issue with long-term PPI use and can cause muscle cramps, irregular heartbeat, and fatigue. Calcium absorption may also be impaired, which connects directly to the next concern.
Bone Fracture Risk
The UK’s Medicines and Healthcare products Regulatory Agency reviewed multiple meta-analyses and concluded that long-term PPI use increases fracture risk by 10 to 40% above baseline. Hip fractures are the primary concern, particularly in older adults. The likely explanation is a combination of reduced calcium absorption and possible direct effects on bone metabolism. If you’re already at risk for osteoporosis due to age, family history, or low body weight, this is a meaningful addition to your risk profile.
Gut Infections
Stomach acid is one of your body’s first defenses against harmful bacteria in food and water. When that acid is suppressed, certain infections become more likely. Health Canada notes that PPI users are slightly more likely to develop Clostridioides difficile infections, a bacterial gut infection that causes severe diarrhea and can be difficult to treat. This warning is already included in the prescribing information for all PPIs in Canada. The risk is particularly relevant for older adults, people in hospitals or long-term care facilities, and anyone recently on antibiotics.
Brain Health and Dementia
The link between PPIs and cognitive decline is one of the more unsettled areas of research. Several observational studies have found that long-term PPI users have a higher rate of both Alzheimer’s disease and non-Alzheimer’s dementia, but the evidence is mixed and no study has proven that PPIs directly cause the problem.
There are plausible biological pathways, though. PPIs cross the blood-brain barrier and may interfere with how brain cells clear waste proteins. B12 deficiency from long-term use can raise levels of a compound called homocysteine, which promotes the buildup of the protein tangles associated with Alzheimer’s. Lab research has also shown that PPIs can disrupt mitochondrial function in brain cells and alter the activity of immune cells in the brain. These findings are concerning enough to take seriously in elderly patients on long-term therapy, even if the final verdict isn’t in.
The Clopidogrel Interaction
If you take the blood thinner clopidogrel (Plavix), omeprazole deserves special attention. Both drugs are processed by the same liver enzyme, and the prescribing information for clopidogrel specifically says to avoid taking it with omeprazole or esomeprazole. The concern is that omeprazole could reduce clopidogrel’s effectiveness at preventing blood clots.
That said, the real-world evidence on this interaction has softened considerably. When researchers looked only at the highest-quality studies (randomized controlled trials and carefully matched observational data), the increased cardiovascular risk from combining the two drugs essentially disappeared. Guidelines from the American Heart Association, European Society of Cardiology, and American College of Gastroenterology now suggest that for patients who genuinely need a PPI for serious reflux or esophageal damage, the benefits of acid suppression likely outweigh the theoretical cardiac risk. The VA’s pharmacy service no longer recommends limiting omeprazole in patients on clopidogrel based on these updated guidelines.
Rebound Acid When You Stop
One reason people stay on omeprazole longer than intended is that stopping can feel worse than the original problem. When you abruptly quit after weeks or months of use, your stomach tends to overshoot on acid production, a phenomenon called rebound acid hypersecretion. This can cause intense heartburn and indigestion that feels like proof you still need the medication, even if you didn’t have significant symptoms before starting it.
Research on healthy volunteers given a PPI for six weeks found that rebound symptoms lasted 10 to 14 days after stopping. The recommended approach is to taper gradually over two to four weeks, with longer tapers for higher doses. Cutting the dose in half, then switching to every-other-day dosing before stopping entirely, gives your stomach time to recalibrate. Over-the-counter antacids can bridge the gap during those uncomfortable days.
Short-Term vs. Long-Term Use
The pattern across nearly all of these risks is the same: they are dose-dependent and time-dependent. A two-week course of omeprazole for a stomach ulcer or a brief flare of acid reflux carries minimal risk for most people. The problems emerge with continuous use over months and years, particularly at higher doses.
Some people have conditions that genuinely require long-term acid suppression, such as Barrett’s esophagus, severe erosive esophagitis, or Zollinger-Ellison syndrome. For them, the benefits clearly justify the risks. The issue is that a large number of long-term users originally started omeprazole for mild heartburn, were never reassessed, and kept refilling the prescription out of habit. If that describes your situation, it’s worth revisiting whether you still need it, and if so, whether the lowest effective dose is what you’re taking.